Michael Kelly

Michael Kelly

Directeur/Membre du Conseil chez PRIME MEDICINE, INC.

Fortune : 2 M $ au 30/09/2026

69 ans
Health Technology
Health Services
Commercial Services

Profil

Michael Anthony Kelly is the founder of Sentry Hill Partners LLC, founded in 2018, where the title held is President.
Current jobs include Independent Director at DMC Global, Inc. since 2020; Lead Independent Director at NeoGenomics, Inc. since 2020; Director at NeoGenomics Laboratories, Inc. since 2020; Independent Director at Prime Medicine, Inc. since 2021; and Director at Chroma Medicine, Inc. since 2023.
Former jobs include Director at Direct Relief; Independent Director at HOOKIPA Pharma, Inc. from 2019 to 2023; Independent Director at Aprea Therapeutics, Inc. from 2020 to 2022; Director at Hookipa Biotech AG from 2019 to 2024; Independent Director at Amicus Therapeutics, Inc. from 2020 to 2026; Senior Vice President-Global Business Services at Amgen, Inc. from 2014 to 2017; Vice President-Finance & Controller at Biogen, Inc. from 1998 to 2000; Chief Financial Officer at Tanox, Inc. from 2000 to 2003; Principal at Onyx Capital Management LLC; Chief Financial Officer & Vice President at The NutraSweet Co. from 1996 to 1998; Chief Financial Officer at Monsanto Life Sciences Co.; and Chief Financial Officer & Vice President-Finance at Nutrasweet Kelco Co. Ltd. from 1996 to 1998.
Education includes undergraduate studies at Florida A&M University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/06/2026 72 086 ( 0,06% ) 1 M $ 30/09/2026
13/05/2026 65 590 ( 0,32% ) 365 992 $ 30/09/2026
05/06/2026 0 ( -.--% ) - $ 30/09/2026

Postes actifs de Michael Kelly

SociétésPosteDébut
NEOGENOMICS, INC. Directeur/Membre du Conseil 15/07/2020
DMC GLOBAL INC. Directeur/Membre du Conseil 24/07/2020
PRIME MEDICINE, INC. Directeur/Membre du Conseil 01/11/2021
Directeur/Membre du Conseil 01/07/2020
Fondateur 01/01/2018
Directeur/Membre du Conseil 27/09/2023

Anciens postes connus de Michael Kelly

SociétésPosteFin
AMICUS THERAPEUTICS, INC. Directeur/Membre du Conseil 27/04/2026
Directeur/Membre du Conseil 18/11/2024
HOOA PHARPAR Directeur/Membre du Conseil 07/04/2023
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Michael Kelly

Formation de Michael Kelly

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

87

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Health Technology

Industrial Services

Health Technology

Health Services

Health Technology

Finance

Health Technology

Process Industries

Consumer Services

Commercial Services

Monsanto Life Sciences Co.

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Nutrasweet Kelco Co. Ltd.

  1. Bourse
  2. Insiders
  3. Michael Kelly